Mettler-Toledo International Inc.
$1,328.56
▲
0.32%
2026-04-22 10:12:13
www.mt.com
NYQ: MTD
Explore Mettler-Toledo International Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$26.93 B
Current Price
$1,328.56
52W High / Low
$1,525.17 / $962.54
Stock P/E
31.6
Book Value
$-1.16
Dividend Yield
—
ROCE
44.48%
ROE
-1154.87%
Face Value
—
EPS
$42.05
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
16,600
Beta
1.44
Debt / Equity
-91.05
Current Ratio
1.14
Quick Ratio
0.81
Forward P/E
25.88
Price / Sales
6.69
Enterprise Value
$29.13 B
EV / EBITDA
24.04
EV / Revenue
7.24
Rating
Buy
Target Price
$1,498.31
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Return on equity is on the weaker side.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Precipio, Inc. | $28.15 | — | $50.21 M | — | -6.84% | -2.72% | $29.8 / $5.19 | $8.18 |
| 2. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
| 3. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
| 4. | CareDx, Inc. | $21.29 | — | $1.11 B | — | -7.75% | -6.27% | $23.24 / $10.96 | $5.95 |
| 5. | Twist Bioscience Corporation | $61.88 | — | $3.79 B | — | -24.75% | -16.79% | $62.09 / $23.3 | $7.44 |
| 6. | ICON Public Limited Company | $114.42 | 15.51 | $8.76 B | — | 8.66% | 6.27% | $211 / $66.57 | $122.25 |
| 7. | Quest Diagnostics Incorporated | $200.41 | 22.15 | $22.16 B | 1.76% | 11.16% | 14.75% | $213.5 / $160.02 | $65.18 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 1.13 B | 1.03 B | 983.22 M | 883.74 M | 1.05 B |
| Operating Profit | 343.34 M | 289.9 M | 265.71 M | 219.54 M | 333.7 M |
| Net Profit | 285.76 M | 217.49 M | 202.35 M | 163.59 M | 252.3 M |
| EPS in Rs | 14.11 | 10.74 | 9.99 | 8.08 | 12.46 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.03 B | 3.87 B | 3.79 B | 3.92 B |
| Operating Profit | 1.12 B | 1.13 B | 1.08 B | 1.13 B |
| Net Profit | 869.19 M | 863.14 M | 788.78 M | 872.5 M |
| EPS in Rs | 42.93 | 42.63 | 38.95 | 43.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.71 B | 3.24 B | 3.36 B | 3.49 B |
| Total Liabilities | 3.74 B | 3.37 B | 3.51 B | 3.47 B |
| Equity | -23.64 M | -126.89 M | -149.94 M | 24.79 M |
| Current Assets | 1.36 B | 1.19 B | 1.23 B | 1.38 B |
| Current Liabilities | 1.2 B | 1.17 B | 1.18 B | 1.15 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 955.77 M | 968.35 M | 965.87 M | 859.07 M |
| Investing CF | -193.87 M | -119.46 M | -131.69 M | -139.4 M |
| Financing CF | -755.17 M | -855.98 M | -859.59 M | -716.04 M |
| Free CF | 848.65 M | 864.45 M | 860.55 M | 737.83 M |
| Capex | -107.12 M | -103.9 M | -105.32 M | -121.24 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 3.98% | 2.22% | -3.35% | — |
| Earnings Growth % | 0.7% | 9.43% | -9.6% | — |
| Profit Margin % | 21.59% | 22.29% | 20.82% | 22.26% |
| Operating Margin % | 27.78% | 29.11% | 28.5% | 28.73% |
| Gross Margin % | 59.37% | 60.06% | 59.16% | 58.88% |
| EBITDA Margin % | 30.87% | 31.89% | 30.94% | 31.61% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.